Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 276581, 9 pages
http://dx.doi.org/10.1155/2008/276581
Research Article

Genetic Polymorphisms of Peroxisome Proliferator-Activated Receptors and the Risk of Cardiovascular Morbidity and Mortality in a Community-Based Cohort in Washington County, Maryland

1Prevention and Research Center, Weinberg Center for Women's Health and Medicine, Mercy Medical Center, 227 Street Paul Place, 6th Floor, Baltimore, MD 21202, USA
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA
3Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room E7535, Baltimore, MD 21205, USA

Received 27 June 2007; Revised 15 September 2007; Accepted 2 October 2007

Academic Editor: Brian N. Finck

Copyright © 2008 L. Gallicchio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. A. Hsueh and D. Bruemmer, “Peroxisome proliferator-activated receptor γ: implications for cardiovascular disease,” Hypertension, vol. 43, no. 2, pp. 297–305, 2004. View at Publisher · View at Google Scholar
  2. R. Bordet, T. Ouk, O. Petrault et al., “PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases,” Biochemical Society Transactions, vol. 34, no. 6, pp. 1341–1346, 2006. View at Publisher · View at Google Scholar
  3. J. P. Berger, T. E. Akiyama, and P. T. Meinke, “PPARs: therapeutic targets for metabolic disease,” Trends in Pharmacological Sciences, vol. 26, no. 5, pp. 244–251, 2005. View at Publisher · View at Google Scholar
  4. R. M. Touyz and E. L. Schiffrin, “Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications,” Vascular Pharmacology, vol. 45, no. 1, pp. 19–28, 2006. View at Publisher · View at Google Scholar
  5. N. Marx, H. Duez, J.-C. Fruchart, and B. Staels, “Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells,” Circulation Research, vol. 94, no. 9, pp. 1168–1178, 2004. View at Publisher · View at Google Scholar
  6. G. Chinetti, S. Griglio, M. Antonucci et al., “Activation of proliferator-activated receptors a and ? induces apoptosis of human monocyte-derived macrophages,” Journal of Biological Chemistry, vol. 273, no. 40, pp. 25573–25580, 1998. View at Publisher · View at Google Scholar
  7. S. Cresci, “The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics,” Expert Opinion on Pharmacotherapy, vol. 6, no. 15, pp. 2577–2591, 2005. View at Publisher · View at Google Scholar
  8. P. M. Ridker, N. R. Cook, S. Cheng et al., “Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 5, pp. 859–863, 2003. View at Publisher · View at Google Scholar
  9. T. Pischon, J. K. Pai, J. E. Manson et al., “Peroxisome proliferator-activated receptor-?2 P12A polymorphism and risk of coronary heart disease in US men and women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 8, pp. 1654–1658, 2005. View at Publisher · View at Google Scholar
  10. M. Blüher, T. Klemm, T. Gerike, H. Krankenberg, G. Schuler, and R. Paschke, “Lack of association between peroxisome proliferator-activated receptor-γ-2 gene variants and the occurrence of coronary heart disease in patients with diabetes mellitus,” European Journal of Endocrinology, vol. 146, no. 4, pp. 545–551, 2002. View at Google Scholar
  11. J. M. Genkinger, E. A. Platz, S. C. Hoffman et al., “C47T polymorphism in manganese superoxide dismutase (MnSOD), antioxidant intake and survival,” Mechanisms of Ageing and Development, vol. 127, no. 4, pp. 371–377, 2006. View at Publisher · View at Google Scholar
  12. H. Y. Huang, L. Thuita, P. Strickland, S. C. Hoffman, G. W. Comstock, and K. J. Helzlsouer, “Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population,” BMC Genetics, vol. 8, pp. 1–7, 2007. View at Publisher · View at Google Scholar
  13. M. Klintschar and F. Neuhuber, “Evaluation of an alkaline lysis method for the extraction of DNA from whole blood and forensic stains for STR analysis,” Journal of Forensic Sciences, vol. 45, no. 3, pp. 669–673, 2000. View at Google Scholar
  14. S. S. Deeb, L. Fajas, M. Nemoto et al., “A Pro12Ala substitution in PPAR?2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity,” Nature Genetics, vol. 20, no. 3, pp. 284–287, 1998. View at Publisher · View at Google Scholar
  15. D. Altshuler, J. N. Hirschhorn, M. Klannemark et al., “The common PPAR? Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes,” Nature Genetics, vol. 26, no. 1, pp. 76–80, 2000. View at Publisher · View at Google Scholar
  16. A. S. F. Doney, B. Fischer, J. E. Cecil et al., “Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes,” Diabetologia, vol. 47, no. 3, pp. 555–558, 2004. View at Publisher · View at Google Scholar
  17. H. Mori, H. Ikegami, Y. Kawaguchi et al., “The Pro12?Ala substitution in PPAR-? is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes,” Diabetes, vol. 50, no. 4, pp. 891–894, 2001. View at Publisher · View at Google Scholar
  18. A. Memisoglu, F. B. Hu, S. E. Hankinson et al., “Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPAR? gene and type 2 diabetes,” Diabetes Care, vol. 26, no. 10, pp. 2915–2917, 2003. View at Publisher · View at Google Scholar
  19. J. C. Florez, K. A. Jablonski, M. W. Sun et al., “Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 4, pp. 1502–1509, 2007. View at Publisher · View at Google Scholar
  20. D. Šrámková, M. Kunešová, V. Hainer, M. Hill, J. Vcelák, and B. Bendlová, “Is a Pro12Ala polymorphism of the PPARγ2 gene related to obesity and type 2 diabetes mellitus in the Czech population?” Annals of the New York Academy of Sciences, vol. 967, pp. 265–273, 2002. View at Google Scholar
  21. V. I. Lindi, M. I. J. Uusitupa, J. Lindström et al., “Association of the Pro12Ala polymorphism in the PPAR-?2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study,” Diabetes, vol. 51, no. 8, pp. 2581–2586, 2002. View at Publisher · View at Google Scholar
  22. R. A. Hegele, H. Cao, S. B. Harris, B. Zinman, A. J. G. Hanley, and C. M. Anderson, “Peroxisome proliferator-activated receptor-γ2 P12A and type 2 diabetes in Canadian Oji-Cree,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 5, pp. 2014–2019, 2000. View at Publisher · View at Google Scholar
  23. M. T. Malecki, J. Frey, T. Klupa et al., “The Pro12Ala polymorphism of PPAR?2 gene and susceptibility to type 2 diabetes mellitus in a Polish population,” Diabetes Research and Clinical Practice, vol. 62, no. 2, pp. 105–111, 2003. View at Publisher · View at Google Scholar
  24. E. J. Rhee, C. H. Kwon, W. Y. Lee et al., “No association of Pro12Ala polymorphism of PPAR-? gene with coronary artery disease in Korean subjects,” Circulation Journal, vol. 71, no. 3, pp. 338–342, 2007. View at Publisher · View at Google Scholar
  25. L. Li, L.-X. Cheng, R. Nsenga, M.-A. He, and T.-C. Wu, “Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population,” Clinical Cardiology, vol. 29, no. 7, pp. 300–304, 2006. View at Publisher · View at Google Scholar